2021 ISPE Asia Pacific Pharmaceutical Manufacturing Conference

Sustainable Implementation of Quality Risk Management

The global pharmaceutical industry continues to face unexpected challenges in responding to the world’s pandemic. The impact on normal operations has been felt in companies of all sizes, with varying types of manufacturing capabilities, no more intensely than in the Asia Pacific region. The 2021 ISPE Asia Pacific Pharmaceutical Manufacturing Conference will address this impact and the most critical issues, with special emphasis on practical application using a series of case studies implementing Quality Risk Management principals.

None
06 May 2021
News & Press Releases
ISPE will convene regulators and industry leaders from around the world at the 2021 ISPE Global Pharmaceutical Regulatory Summit on 16 June and at the 2021 ISPE Asia Pacific Pharmaceutical Manufacturing Conference on 17–18 June 2021. Taking place...
Video
The global pharmaceutical industry continues to face unexpected challenges in responding to the world’s pandemic. The impact on normal operations has been felt in companies of all sizes, with varying manufacturing...
Video
The global pharmaceutical industry continues to face unexpected challenges in responding to the world’s pandemic. The impact on normal operations has been felt in companies of all sizes, with varying manufacturing...
Video
The global pharmaceutical industry continues to face unexpected challenges in responding to the world’s pandemic. The impact on normal operations has been felt in companies of all sizes, with varying manufacturing...